Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80
Document › Details

Atlas Antibodies AB. (8/20/21). "Press Release: Atlas Antibodies AB Appoints Nille Klæbel as New CEO".

Organisations Organisation Atlas Antibodies AB
  Group Atlas Antibodies (Group)
  Organisation 2 Philips (Group)
Products Product proteomics
  Product 2 research reagent
Persons Person Klæbel, Nille (Atlas Antibodies 202109– CEO before Philips Nordics + GSK + Sanofi + Novo Nordisk)
  Person 2 Jørgensen, Torben (Biotage 200604–201910 CEO before Affibody CEO before Karo Bio before Dako)
     


Atlas Antibodies is pleased to announce Nille Klæbel as the new CEO with effect from 15 September 2021.

Nille Klæbel joins Atlas Antibodies from her role as CEO Nordics at Philips, a position she has held since 2018. Nille joined Philips back in 2013. Previously she has held senior positions at GlaxoSmithKline, Sanofi and Novo Nordisk.

“We are delighted to welcome Nille as the new CEO of Atlas Antibodies” says Torben Jørgensen, chairman of the Board of Directors and continues: “With her strong background in marketing and sales and knowledge of the life sciences, pharma and healthcare industries, Nille is highly equipped to lead the next important steps in the development of Atlas Antibodies into a global life sciences company.”

“I am thrilled to join Atlas Antibodies. The company is at a truly exciting stage right now, having completed two strategic acquisitions. I look forward to contribute to our continued journey of both organic as well as inorganic growth.”, says Nille Klæbel.

“I also want to thank John Daicic for his commitment, passion and drive during the last four years bringing Atlas Antibodies from being a research company to a much more commercial driven company, including completing two important acquisitions this year. I wish John all the best in his future engagements and career.”, says Torben Jörgensen.


Atlas Antibodies was founded in 2006 as a start-up from the Human Protein Atlas project and has over the last 15 years successfully launched more than 60,000 products for protein research. The company was founded by researchers at the Royal Institute of Technology (KTH) in Stockholm and the Rudbeck Laboratory, Uppsala University in Uppsala to handle the production, marketing and sales of research tools developed by the Swedish-based Human Protein Atlas program. Headquartered in Stockholm, Sweden, Atlas Antibodies provides high-quality reagents for biomedical research, including polyclonal and monoclonal antibodies and QPrESTs. Earlier this year, Atlas Antibodies acquired UK-based HistoCyte Laboratories – a leading supplier of cell line controls for pathology applications, and Swiss-based evitria – an expert provider of antibody expression services.


For more information, please contact:

Torben Jørgensen, chairman of the Board of Directors
torjor100@gmail.com /+46 707490584

   
Record changed: 2021-12-26

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Atlas Antibodies (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px




» top